ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Epidemiology and Prevention
Sociodemographic Determinants and Assessment of Anti-α-Gal IgG Titers in Head and Neck Cancer Patients
Provisionally accepted
Dayse M.S. Lopes1
Cristina Paixao Duraes1Clarissa Fernandes Gomes1Larissa Lopes Fonseca1Sara P.S. Costa1Andre L.S. Guimaraes1Sonia R. Arruda1Guilherme A Lacerda1M.G. Finn2Silvio F.G. Carvalho1
Alexandre F Marques3*Ana Paula V. Moura1- 1Universidade Estadual de Montes Claros Centro de Ciencias Biologicas e da Saude, Montes Claros, Brazil
- 2Georgia Institute of Technology, Atlanta, United States
- 3University of Southern Mississippi, Hattiesburg, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Head and neck cancer (HNC) remains a pressing global health challenge, particularly in regions with lower socioeconomic status, where risk behaviors such as tobacco use and alcohol consumption are prevalent. Despite advances in treatment, reliable biomarkers for the early detection and monitoring of HNC remain lacking. The α-Gal carbohydrate epitope, absent in humans but present in other mammals, has garnered interest due to the natural presence of anti-α-Gal antibodies in the human immune repertoire, comprising approximately 1% of total circulating IgG. We investigated the role of anti-α-Gal IgG as a potential biomarker by performing ELISA on serum samples from a cohort of 11 patients diagnosed with squamous cell carcinoma (SCC) of the head and neck. Eight were older male patients, most of whom lived in rural areas and engaged in manual occupations. High rates of tobacco (81.8%) and alcohol consumption (63.6%) were observed, in line with established risk factors for HNC. These individuals showed significantly elevated anti-α-Gal antibody titers compared to non-cancer controls. Chemotherapy with cisplatin did not markedly affect antibody levels, suggesting consistent immune reactivity across treatment status. These results suggest that anti-α-Gal antibodies may serve as promising biomarker candidates in HNC and warrant further investigation to clarify their potential diagnostic and immunotherapeutic applications.
Keywords: Alpha-Gal, Head and Neck Neoplasms, Virus-like particles, Carbohydrates, Cancer, Cancer
Received: 14 Aug 2025; Accepted: 19 Nov 2025.
Copyright: © 2025 Lopes, Duraes, Gomes, Fonseca, Costa, Guimaraes, Arruda, Lacerda, Finn, Carvalho, Marques and Moura. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Alexandre F Marques, alexandre.marques@usm.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.